Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 162

1.

Artificial-intelligence-based detection of pharyngeal cancer using convolutional neural networks.

Tamashiro A, Yoshio T, Ishiyama A, Tsuchida T, Hijikata K, Yoshimizu S, Horiuchi Y, Hirasawa T, Seto A, Sasaki T, Fujisaki J, Tada T.

Dig Endosc. 2020 Feb 16. doi: 10.1111/den.13653. [Epub ahead of print]

PMID:
32064684
2.

Application of artificial intelligence using convolutional neural networks in determining the invasion depth of esophageal squamous cell carcinoma.

Tokai Y, Yoshio T, Aoyama K, Horie Y, Yoshimizu S, Horiuchi Y, Ishiyama A, Tsuchida T, Hirasawa T, Sakakibara Y, Yamada T, Yamaguchi S, Fujisaki J, Tada T.

Esophagus. 2020 Jan 24. doi: 10.1007/s10388-020-00716-x. [Epub ahead of print]

PMID:
31980977
3.

Macroscopic and microscopic morphology and molecular profiling to distinguish heterogeneous traditional serrated adenomas of the colorectum.

Chino A, Kawachi H, Takamatsu M, Hatamori H, Ide D, Saito S, Igarashi M, Fujisaki J, Nagayama S.

Dig Endosc. 2019 Dec 12. doi: 10.1111/den.13603. [Epub ahead of print]

PMID:
31833094
4.

Clinical impact of Epstein-Barr virus status on the incidence of lymph node metastasis in early gastric cancer.

Osumi H, Kawachi H, Yoshio T, Fujisaki J.

Dig Endosc. 2019 Nov 24. doi: 10.1111/den.13584. [Epub ahead of print] Review.

PMID:
31762090
5.

Pretreatment diagnosis factors associated with overtreatment with surgery in patients with differentiated-type early gastric cancer.

Horiuchi Y, Fujisaki J, Yamamoto N, Ida S, Yoshimizu S, Ishiyama A, Yoshio T, Hirasawa T, Yamamoto Y, Nagahama M, Takahashi H, Tsuchida T.

Sci Rep. 2019 Oct 25;9(1):15356. doi: 10.1038/s41598-019-51952-w.

6.

Clinicopathological characteristics and frequency of multiple rectal neuroendocrine tumors: a single-center retrospective study.

Nishikawa Y, Chino A, Ide D, Saito S, Igarashi M, Takamatsu M, Fujisaki J, Igarashi Y.

Int J Colorectal Dis. 2019 Nov;34(11):1887-1894. doi: 10.1007/s00384-019-03405-z. Epub 2019 Oct 19.

PMID:
31630212
7.

Convolutional Neural Network for Differentiating Gastric Cancer from Gastritis Using Magnified Endoscopy with Narrow Band Imaging.

Horiuchi Y, Aoyama K, Tokai Y, Hirasawa T, Yoshimizu S, Ishiyama A, Yoshio T, Tsuchida T, Fujisaki J, Tada T.

Dig Dis Sci. 2019 Oct 4. doi: 10.1007/s10620-019-05862-6. [Epub ahead of print]

PMID:
31584138
8.

Feasibility of further expansion of the indications for endoscopic submucosal dissection in undifferentiated-type early gastric cancer.

Horiuchi Y, Ida S, Yamamoto N, Nunobe S, Ishizuka N, Yoshimizu S, Ishiyama A, Yoshio T, Hirasawa T, Tsuchida T, Kumagai K, Ohashi M, Sano T, Fujisaki J.

Gastric Cancer. 2019 Sep 5. doi: 10.1007/s10120-019-01003-0. [Epub ahead of print]

PMID:
31486980
9.

Phenotypic variations of gastric neoplasms in familial adenomatous polyposis are associated with endoscopic status of atrophic gastritis.

Nakano K, Kawachi H, Chino A, Kita M, Arai M, Ide D, Saito S, Yoshimizu S, Horiuchi Y, Ishiyama A, Yoshio T, Hirasawa T, Tsuchida T, Fujisaki J.

Dig Endosc. 2019 Aug 14. doi: 10.1111/den.13512. [Epub ahead of print]

PMID:
31411765
10.

Endoscopic features of esophageal adenocarcinoma derived from short-segment versus long-segment Barrett's esophagus.

Yamasaki A, Shimizu T, Kawachi H, Yamamoto N, Yoshimizu S, Horiuchi Y, Ishiyama A, Yoshio T, Hirasawa T, Tsuchida T, Sasaki Y, Fujisaki J.

J Gastroenterol Hepatol. 2020 Feb;35(2):211-217. doi: 10.1111/jgh.14827. Epub 2019 Sep 1.

PMID:
31396997
11.

Additive Effect of Magnifying Endoscopy with Narrow-Band Imaging for Diagnosing Mixed-Type Early Gastric Cancers.

Horiuchi Y, Tokai Y, Yamamoto N, Yoshimizu S, Ishiyama A, Yoshio T, Hirasawa T, Yamamoto Y, Nagahama M, Takahashi H, Tsuchida T, Fujisaki J.

Dig Dis Sci. 2020 Feb;65(2):591-599. doi: 10.1007/s10620-019-05762-9. Epub 2019 Jul 31.

PMID:
31367881
12.

Enterochromaffin-like cell neuroendocrine tumor associated with parietal cell dysfunction.

Ishioka M, Hirasawa T, Kawachi H, Nakano K, Kunieda J, Yoshimizu S, Horiuchi Y, Ishiyama A, Yoshio T, Tsuchida T, Fujisaki J.

Gastrointest Endosc. 2019 Nov;90(5):841-845.e1. doi: 10.1016/j.gie.2019.06.029. Epub 2019 Jul 2. No abstract available.

PMID:
31276673
13.

Colorectal endoscopic submucosal dissection can be efficiently performed by a trainee with use of a simple traction device and expert supervision.

Ide D, Saito S, Ohya TR, Nishikawa Y, Horie Y, Yasue C, Chino A, Igarashi M, Saruta M, Fujisaki J.

Endosc Int Open. 2019 Jun;7(6):E824-E832. doi: 10.1055/a-0901-7113. Epub 2019 Jun 12.

14.

Risk stratification for lymph node metastasis using Epstein-Barr virus status in submucosal invasive (pT1) gastric cancer without lymphovascular invasion: a multicenter observational study.

Osumi H, Kawachi H, Murai K, Kusafuka K, Inoue S, Kitamura M, Yoshio T, Kakusima N, Ishihara R, Ono H, Yamamoto N, Sugino T, Nakatsuka S, Ida S, Nunobe S, Bando E, Omori T, Takeuchi K, Fujisaki J.

Gastric Cancer. 2019 Nov;22(6):1176-1182. doi: 10.1007/s10120-019-00963-7. Epub 2019 May 6.

PMID:
31062195
15.

Efficacy of novel sedation using the combination of dexmedetomidine and midazolam during endoscopic submucosal dissection for esophageal squamous cell carcinoma.

Yoshio T, Ishiyama A, Tsuchida T, Yoshimizu S, Horiuchi Y, Omae M, Hirasawa T, Yamamoto Y, Sano H, Yokota M, Fujisaki J.

Esophagus. 2019 Jul;16(3):285-291. doi: 10.1007/s10388-019-00666-z. Epub 2019 Apr 1.

PMID:
30937573
16.

[Endoscopic Diagnosis Using Artificial Intelligence].

Hirasawa T, Ikenoyama Y, Horie Y, Ishioka M, Tamashiro A, Shiroma S, Namikawa K, Nakano K, Tokai Y, Yoshimizu S, Horiuchi Y, Ishiyama A, Yoshio T, Tsuchida T, Fujisaki J.

Gan To Kagaku Ryoho. 2019 Mar;46(3):412-417. Japanese.

PMID:
30914574
17.

Epstein-Barr virus status is a promising biomarker for endoscopic resection in early gastric cancer: proposal of a novel therapeutic strategy.

Osumi H, Kawachi H, Yoshio T, Ida S, Yamamoto N, Horiuchi Y, Ishiyama A, Hirasawa T, Tsuchida T, Hiki N, Takeuchi K, Fujisaki J.

J Gastroenterol. 2019 Sep;54(9):774-783. doi: 10.1007/s00535-019-01562-0. Epub 2019 Mar 2.

PMID:
30826866
18.

Incidence of metachronous gastric cancer in patients whose primary gastric neoplasms were discovered after Helicobacter pylori eradication.

Okada K, Suzuki S, Naito S, Yamada Y, Haruki S, Kubota M, Nakajima Y, Shimizu T, Ando K, Uchida Y, Hirasawa T, Fujisaki J, Tsuchida T.

Gastrointest Endosc. 2019 Jun;89(6):1152-1159.e1. doi: 10.1016/j.gie.2019.02.026. Epub 2019 Feb 27.

PMID:
30825537
19.

Pathological risk factors and predictive endoscopic factors for lymph node metastasis of T1 colorectal cancer: a single-center study of 846 lesions.

Yasue C, Chino A, Takamatsu M, Namikawa K, Ide D, Saito S, Igarashi M, Fujisaki J.

J Gastroenterol. 2019 Aug;54(8):708-717. doi: 10.1007/s00535-019-01564-y. Epub 2019 Feb 27.

PMID:
30810812
20.

Enrichment of CLDN18-ARHGAP fusion gene in gastric cancers in young adults.

Nakayama I, Shinozaki E, Sakata S, Yamamoto N, Fujisaki J, Muramatsu Y, Hirota T, Takeuchi K, Takahashi S, Yamaguchi K, Noda T.

Cancer Sci. 2019 Apr;110(4):1352-1363. doi: 10.1111/cas.13967.

21.

A suitable marking method to achieve lateral margin negative in endoscopic submucosal dissection for undifferentiated-type early gastric cancer.

Yoshimizu S, Yamamoto Y, Horiuchi Y, Yoshio T, Ishiyama A, Hirasawa T, Tsuchida T, Fujisaki J.

Endosc Int Open. 2019 Feb;7(2):E274-E281. doi: 10.1055/a-0812-3222. Epub 2019 Jan 30.

22.

Efficacy and safety of 0.6% sodium alginate solution in endoscopic submucosal dissection for esophageal and gastric neoplastic lesion: A randomized controlled study.

Uemura N, Oda I, Saito Y, Ono H, Fujisaki J, Matsuhashi N, Ohata K, Yahagi N, Yada T, Satoh M, Tajiri H, Inomata M, Kitano S.

Dig Endosc. 2019 Jul;31(4):396-404. doi: 10.1111/den.13352. Epub 2019 Mar 18.

23.

Prospective feasibility study for single-tracer sentinel node mapping by ICG (indocyanine green) fluorescence and OSNA (one-step nucleic acid amplification) assay in laparoscopic gastric cancer surgery.

Shoji Y, Kumagai K, Kamiya S, Ida S, Nunobe S, Ohashi M, Yoshimizu S, Horiuchi Y, Yoshio T, Ishiyama A, Hirasawa T, Osako T, Yamamoto N, Fujisaki J, Sano T, Hiki N.

Gastric Cancer. 2019 Jul;22(4):873-880. doi: 10.1007/s10120-018-00919-3. Epub 2019 Jan 3.

PMID:
30603913
24.

Efficacy and safety of endoscopic resection for gastric tube cancer after surgical resection of esophageal squamous cell carcinoma.

Hirayama Y, Fujisaki J, Yoshimizu S, Horiuchi Y, Yoshio T, Ishiyama A, Hirasawa T, Imamura Y, Mine S, Watanabe M, Tsuchida T.

Esophagus. 2019 Apr;16(2):194-200. doi: 10.1007/s10388-018-00653-w. Epub 2019 Jan 1.

PMID:
30600485
25.

Villous colonization (glove balloon sign): A histopathological diagnostic marker for follicular lymphomas with duodenal involvement including duodenal-type follicular lymphoma.

Tsuyama N, Yokoyama M, Fujisaki J, Oguchi M, Terui Y, Takeuchi K.

Pathol Int. 2019 Jan;69(1):48-50. doi: 10.1111/pin.12740. Epub 2018 Dec 24. No abstract available.

PMID:
30582768
26.

Long-term outcomes of endoscopic resection and metachronous cancer after endoscopic resection for adenocarcinoma of the esophagogastric junction in Japan.

Abe S, Ishihara R, Takahashi H, Ono H, Fujisaki J, Matsui A, Takahashi A, Goda K, Kawada K, Koike T, Takeuchi M, Tsuji Y, Hirasawa D, Oyama T.

Gastrointest Endosc. 2019 Jun;89(6):1120-1128. doi: 10.1016/j.gie.2018.12.010. Epub 2018 Dec 18.

PMID:
30576649
27.

CD150high CD4 T cells and CD150high regulatory T cells regulate hematopoietic stem cell quiescence via CD73.

Hirata Y, Kakiuchi M, Robson SC, Fujisaki J.

Haematologica. 2019 Jun;104(6):1136-1142. doi: 10.3324/haematol.2018.198283. Epub 2018 Dec 13.

28.

Correction to: Clinical significance of intratumoral HER2 heterogeneity on trastuzumab efficacy using endoscopic biopsy specimens in patients with advanced HER2 positive gastric cancer.

Yagi S, Wakatsuki T, Yamamoto N, Chin K, Takahari D, Ogura M, Ichimura T, Nakayama I, Osumi H, Shinozaki E, Suenaga M, Fujisaki J, Ishikawa Y, Yamaguchi K, Namikawa K, Horiuchi Y.

Gastric Cancer. 2019 May;22(3):526. doi: 10.1007/s10120-018-0900-4.

29.

Clinical significance of intratumoral HER2 heterogeneity on trastuzumab efficacy using endoscopic biopsy specimens in patients with advanced HER2 positive gastric cancer.

Yagi S, Wakatsuki T, Yamamoto N, Chin K, Takahari D, Ogura M, Ichimura T, Nakayama I, Osumi H, Shinozaki E, Suenaga M, Fujisaki J, Ishikawa Y, Yamaguchi K, Namikawa K, Horiuchi Y.

Gastric Cancer. 2019 May;22(3):518-525. doi: 10.1007/s10120-018-0887-x. Epub 2018 Oct 17. Erratum in: Gastric Cancer. 2018 Nov 22;:.

30.

Differences in upper gastrointestinal neoplasm detection rates based on inspection time and esophagogastroduodenoscopy training.

Yoshimizu S, Hirasawa T, Horiuchi Y, Omae M, Ishiyama A, Yoshio T, Tsuchida T, Fujisaki J.

Endosc Int Open. 2018 Oct;6(10):E1190-E1197. doi: 10.1055/a-0655-7382. Epub 2018 Oct 8.

31.

Giant duodenal Brunner's gland hamartoma successfully treated via endoscopic mucosal resection.

Kitagawa Y, Osumi H, Kawachi H, Yoshio T, Yoshimizu S, Horiuchi Y, Ishiyama A, Hirasawa T, Tsuchida T, Fujisaki J.

Arab J Gastroenterol. 2018 Sep;19(3):125-129. doi: 10.1016/j.ajg.2018.08.004. Epub 2018 Sep 20.

PMID:
30243896
32.

Long-term outcomes of combined endoscopic resection and chemoradiotherapy for esophageal squamous cell carcinoma with submucosal invasion. Author's reply.

Yoshimizu S, Yoshio T, Ishiyama A, Tsuchida T, Horiuchi Y, Omae M, Hirasawa T, Asari T, Chin K, Fujisaki J.

Dig Liver Dis. 2018 Nov;50(11):1255-1256. doi: 10.1016/j.dld.2018.07.044. Epub 2018 Aug 25. No abstract available.

PMID:
30224315
33.

Clinicopathological Features of Metastatic Gastric Tumors Originating From Breast Cancer: Analysis of Eleven Cases.

Ushida Y, Yoshimizu S, Horiuchi Y, Yoshio T, Ishiyama A, Hirasawa T, Tsuchida T, Fujisaki J.

World J Oncol. 2018 Aug;9(4):104-109. doi: 10.14740/wjon1112w. Epub 2018 Sep 6.

34.

Diagnostic outcomes of esophageal cancer by artificial intelligence using convolutional neural networks.

Horie Y, Yoshio T, Aoyama K, Yoshimizu S, Horiuchi Y, Ishiyama A, Hirasawa T, Tsuchida T, Ozawa T, Ishihara S, Kumagai Y, Fujishiro M, Maetani I, Fujisaki J, Tada T.

Gastrointest Endosc. 2019 Jan;89(1):25-32. doi: 10.1016/j.gie.2018.07.037. Epub 2018 Aug 16.

PMID:
30120958
35.

Early detection of gastric cancer after Helicobacter pylori eradication due to endoscopic surveillance.

Sakitani K, Nishizawa T, Arita M, Yoshida S, Kataoka Y, Ohki D, Yamashita H, Isomura Y, Toyoshima A, Watanabe H, Iizuka T, Saito Y, Fujisaki J, Yahagi N, Koike K, Toyoshima O.

Helicobacter. 2018 Aug;23(4):e12503. doi: 10.1111/hel.12503. Epub 2018 Jun 20.

36.

Newly developed magnifying endoscopic classification of the Japan Esophageal Society to identify superficial Barrett's esophagus-related neoplasms.

Goda K, Fujisaki J, Ishihara R, Takeuchi M, Takahashi A, Takaki Y, Hirasawa D, Momma K, Amano Y, Yagi K, Furuhashi H, Shimizu T, Kanesaka T, Hashimoto S, Ono Y, Yamagata T, Fujiwara J, Azumi T, Nishikawa M, Watanabe G, Ohkura Y, Oyama T.

Esophagus. 2018 Jun 19. doi: 10.1007/s10388-018-0623-y. [Epub ahead of print]

37.

Adjusting the length and direction of the redundant duodenal stent using a detachable snare and endoclips.

Sasaki T, Yoshio T, Fujisaki J.

Dig Endosc. 2018 Sep;30(5):686-687. doi: 10.1111/den.13186. Epub 2018 Jun 13. No abstract available.

PMID:
29763988
38.

Endoscopic criteria to evaluate tumor response of rectal cancer to neoadjuvant chemoradiotherapy using magnifying chromoendoscopy.

Chino A, Konishi T, Ogura A, Kawachi H, Osumi H, Yoshio T, Kishihara T, Ide D, Saito S, Igarashi M, Akiyoshi T, Ueno M, Fujisaki J.

Eur J Surg Oncol. 2018 Aug;44(8):1247-1253. doi: 10.1016/j.ejso.2018.04.013. Epub 2018 Apr 25.

PMID:
29731188
39.

Reply to the letter to the editor: Lymph node metastasis of adenocarcinoma and different definitions of sm1 cancer in the esophagus.

Ishihara R, Oyama T, Abe S, Takahashi H, Ono H, Fujisaki J, Kaise M, Goda K, Kawada K, Koike T, Takeuchi M, Matsuda R, Hirasawa D, Yamada M, Kodaira J, Tanaka M, Omae M, Matsui A, Kanesaka T, Takahashi A, Hirooka S, Saito M, Tsuji Y, Maeda Y, Yamashita H, Oda I, Tomita Y, Matsunaga T, Terai S, Ozawa S, Kawano T, Seto Y.

J Gastroenterol. 2018 Jun;53(6):804-805. doi: 10.1007/s00535-018-1463-1. No abstract available.

PMID:
29611011
40.

Undifferentiated-type component mixed with differentiated-type early gastric cancer is a significant risk factor for endoscopic non-curative resection.

Horiuchi Y, Fujisaki J, Yamamoto N, Ishizuka N, Omae M, Ishiyama A, Yoshio T, Hirasawa T, Yamamoto Y, Nagahama M, Takahashi H, Tsuchida T.

Dig Endosc. 2018 Sep;30(5):624-632. doi: 10.1111/den.13059. Epub 2018 Apr 17.

PMID:
29570860
41.

Treatment Outcomes of Endoscopic Submucosal Dissection for Adenocarcinoma Originating from Long-Segment Barrett's Esophagus versus Short-Segment Barrett's Esophagus.

Shimizu T, Fujisaki J, Omae M, Yamasaki A, Horiuchi Y, Ishiyama A, Yoshio T, Hirasawa T, Yamamoto Y, Tsuchida T.

Digestion. 2018;97(4):316-323. doi: 10.1159/000486197. Epub 2018 Mar 14.

PMID:
29539629
42.

Diagnostic accuracy of demarcation using magnifying endoscopy with narrow-band imaging for Helicobacter pylori-uninfected undifferentiated-type early gastric cancer.

Horiuchi Y, Fujisaki J, Yamamoto N, Yoshimizu S, Ishiyama A, Yoshio T, Hirasawa T, Yamamoto Y, Nagahama M, Takahashi H, Tsuchida T.

Gastric Cancer. 2018 Nov;21(6):988-997. doi: 10.1007/s10120-018-0819-9. Epub 2018 Mar 13.

PMID:
29536297
43.

Long-term outcomes of combined endoscopic resection and chemoradiotherapy for esophageal squamous cell carcinoma with submucosal invasion.

Yoshimizu S, Yoshio T, Ishiyama A, Tsuchida T, Horiuchi Y, Omae M, Hirasawa T, Asari T, Chin K, Fujisaki J.

Dig Liver Dis. 2018 Aug;50(8):833-838. doi: 10.1016/j.dld.2018.01.138. Epub 2018 Feb 7.

PMID:
29477349
44.

CD150high Bone Marrow Tregs Maintain Hematopoietic Stem Cell Quiescence and Immune Privilege via Adenosine.

Hirata Y, Furuhashi K, Ishii H, Li HW, Pinho S, Ding L, Robson SC, Frenette PS, Fujisaki J.

Cell Stem Cell. 2018 Mar 1;22(3):445-453.e5. doi: 10.1016/j.stem.2018.01.017. Epub 2018 Feb 15.

45.

Application of artificial intelligence using a convolutional neural network for detecting gastric cancer in endoscopic images.

Hirasawa T, Aoyama K, Tanimoto T, Ishihara S, Shichijo S, Ozawa T, Ohnishi T, Fujishiro M, Matsuo K, Fujisaki J, Tada T.

Gastric Cancer. 2018 Jul;21(4):653-660. doi: 10.1007/s10120-018-0793-2. Epub 2018 Jan 15.

PMID:
29335825
46.

Vonoprazan is Superior to Rabeprazole for Healing Endoscopic Submucosal Dissection: Induced Ulcers.

Yamasaki A, Yoshio T, Muramatsu Y, Horiuchi Y, Ishiyama A, Hirasawa T, Tsuchida T, Sasaki Y, Fujisaki J.

Digestion. 2018;97(2):170-176. doi: 10.1159/000485028. Epub 2018 Jan 8.

PMID:
29310111
47.

Mixed poorly differentiated adenocarcinoma in undifferentiated-type early gastric cancer predicts endoscopic noncurative resection.

Horiuchi Y, Fujisaki J, Yamamoto N, Ishizuka N, Omae M, Ishiyama A, Yoshio T, Hirasawa T, Yamamoto Y, Nagahama M, Takahashi H, Tsuchida T.

Gastric Cancer. 2018 Jul;21(4):689-695. doi: 10.1007/s10120-017-0788-4. Epub 2017 Dec 13.

PMID:
29236187
48.

Study on Clinical Factors Involved in Helicobacter pylori-Uninfected, Undifferentiated-Type Early Gastric Cancer.

Horiuchi Y, Fujisaki J, Ishizuka N, Omae M, Ishiyama A, Yoshio T, Hirasawa T, Yamamoto Y, Nagahama M, Takahashi H, Tsuchida T.

Digestion. 2017 Nov;96(4):213-219. doi: 10.1159/000481817. Epub 2017 Oct 19.

PMID:
29050004
49.

A significant increase in the pepsinogen I/II ratio is a reliable biomarker for successful Helicobacter pylori eradication.

Osumi H, Fujisaki J, Suganuma T, Horiuchi Y, Omae M, Yoshio T, Ishiyama A, Tsuchida T, Miki K.

PLoS One. 2017 Aug 30;12(8):e0183980. doi: 10.1371/journal.pone.0183980. eCollection 2017.

50.

Diagnostic performance of routine esophagogastroduodenoscopy using magnifying endoscope with narrow-band imaging for gastric cancer.

Yoshimizu S, Yamamoto Y, Horiuchi Y, Omae M, Yoshio T, Ishiyama A, Hirasawa T, Tsuchida T, Fujisaki J.

Dig Endosc. 2018 Jan;30(1):71-78. doi: 10.1111/den.12916. Epub 2017 Aug 23.

PMID:
28685858

Supplemental Content

Loading ...
Support Center